Trial Profile
Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1) (OBSERVER)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2011
Price :
$35
*
At a glance
- Drugs Interferon alfacon-1 (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms OBSERVER
- Sponsors Closter Pharma
- 02 Sep 2011 New trial record